Trademark Overview
On Friday, June 6, 2025, a trademark application was filed for LACOSTIM with the United States Patent and Trademark Office. The USPTO has given the LACOSTIM trademark a serial number of 99222258. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 6, 2025. This trademark is owned by UTC Therapeutics (Shanghai) CO., LTD.. The LACOSTIM trademark is filed in the Pharmaceutical Products category with the following description:
Anti-cancer preparations; Human vaccine preparations; Tumor suppressing agents; Vaccine adjuvants; Cellular function activating agents for medical purposes; Pharmaceutical preparations for the treatment and prevention of cancer and autoimmune diseases; Clinical medical reagents; Biological preparations for the treatment of cancer and autoimmune diseases; Cells for medical or clinical use; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer and autoimmune diseases; Pharmaceutical preparations for suppressing tumors; Immunostimulants; Cytostatics for medical purposes; Medical preparations for the treatment of cancer and autoimmune diseases; Biochemical reagents for medical or veterinary purposes; Pharmaceutical preparations containing cultured cells for cancer and autoimmune diseases; Biopharmaceutical preparations for the treatment of cancer and autoimmune diseases; Antibodies for medical purposes; Biological reagen...
